(Q47673541)

English

Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

1 reference

based on heuristic

inferred from title

author name string

Xin Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Jun Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Lu Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Li Mao

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Tongtong An

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Hua Bai

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Shuhang Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Xuyi Liu

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Guoshuang Feng

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Jie Wang

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

publication date

2 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

27

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

484-490

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

https://scigraph.springernature.com/pub.10.1007/s12032-009-9239-3

0 references

Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Future

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9239-3

21 January 2018

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting the outcome of chemotherapy for lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanism of nucleotide excision repair.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression profiling of non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Mortality time trends and the incidence and mortality estimation and projection for lung cancer in China].

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERCC1 and non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/19488864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-009-9239-3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19488864

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47673541&oldid=2164928547"